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nottingham.ac.ukAbstractThe Siberian hamster (Phodopus sungorus) survives winter by decreasing food intake and
catabolizing abdominal fat reserves, resulting in a sustained, profound loss of body weight.
Hypothalamic tanycytes are pivotal for this process. In these cells, short-winter photoperiods
upregulate deiodinase 3, an enzyme that regulates thyroid hormone availability, and
downregulate genes encoding components of retinoic acid (RA) uptake and signaling.
The aim of the current studies was to identify mechanisms by which seasonal changes in
thyroid hormone and RA signaling from tanycytes might ultimately regulate appetite and
energy expenditure. proVGF is one of the most abundant peptides in the mammalian brain,
and studies have suggested a role for VGF-derived peptides in the photoperiodic regulation
of body weight in the Siberian hamster. In silico studies identified possible thyroid and
vitamin D response elements in the VGF promoter. Using the human neuroblastoma SH-SY5Y
cell line, we demonstrate that RA increases endogenous VGF expression (P!0.05) and VGF
promoter activity (P!0.0001). Similarly, treatment with 1,25-dihydroxyvitamin D3 increased
endogenous VGF mRNA expression (P!0.05) and VGF promoter activity (P!0.0001),
whereas triiodothyronine (T3) decreased both (P!0.01 and P!0.0001). Finally, intra-
hypothalamic administration of T3 blocked the short day-induced increase in VGF expression
in the dorsomedial posterior arcuate nucleus of Siberian hamsters. Thus, we conclude that
VGF expression is a likely target of photoperiod-induced changes in tanycyte-derived signals
and is potentially a regulator of seasonal changes in appetite and energy expenditure.Keywords
" VGF (non-acronymic)
" thyroid hormone
" SH-SY5Y cells
" Siberian hamster
" vitamin Dicen
.0 UJournal of Molecular
Endocrinology
(2016) 56, 123–134IntroductionThe Siberian hamster (Phodopus sungorus) has been
increasingly used to investigate hypothalamic mecha-
nisms regulating energy homeostasis due to its natural
seasonal cycle of appetite, energy expenditure, and body
weight (Ebling 2014). These hamsters naturally become
obese in the summer long-day photoperiod (LD), but then
enter a catabolic state during winter short-day photoperiod(SD) where they reduce their food intake and catabolize
intra-abdominal fat reserves, subsequently losing up to a
third of their body weight (Bartness et al. 1989, Klingenspor
et al. 1996, Mercer et al. 2001). The mechanism(s) by which
these long-term changes in body weight are regulated
are poorly understood, but they are clearly distinct from
those governing short-term homeostatic regulation ofsed under a Creative Commons
nported License.
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ependymal wall lining the hypothalamic third ventricle
of Siberian hamsters housed in different photoperiods
(Barrett et al. 2005, 2006). Much recent interest has focused
on tanycytes as the key component of the ependyma, as
these cells are clearly important nutrient sensors in the
hypothalamus, and also a stem cell niche (Bolborea & Dale
2013, Robins et al. 2013). For example, SD photoperiod
upregulates expression of deiodinase 3 (DIO3), the enzyme
responsible for degrading active 3,5,3 0-triiodothyronine
(T3) to inactive 3,3
0-diiodothyronine (T2), as well as
the conversion of thyroxine (T4) to the inactive
3,3 0,5-triodothyronine, also called reverse T3 or rT3 (Barrett
et al. 2005, 2006, 2007). A number of genes encoding
components of retinoic acid (RA) uptake and signaling are
also downregulated by SD in tanycytes (Ross et al. 2004,
Shearer et al. 2010). The major question now arises as
to how seasonal changes in thyroid hormone and RA
signaling from tanycytes to hypothalamic neurons
ultimately regulate appetite and energy expenditure.
One of the most abundant peptidergic genes
expressed in the mammalian brain, and particularly the
hypothalamus, is VGF (non-acronymic) (Levi et al. 2004,
Lewis et al. 2015b), a gene first identified on the basis of its
rapid induction in vitro by nerve growth factor (NGF) in
PC12 cells, a rat neuroblastic cell line (Levi et al. 1985).
It has subsequently been shown that RA, in addition to
NGF, can act as a transcriptional inducer of the VGF gene
in SK-N-BE (a human neuroblastoma cell line) and PC12
cells (Salton et al. 1991, Rossi et al. 1992, Cerchia et al.
2006). Hypothalamic VGF mRNA expression is altered by
photoperiod in Siberian hamsters, with significantly lower
expression in SD compared to LD in the arcuate nucleus
(ARC), but intriguingly upregulation in a specific sub-
division of the ARC, the dorsomedial posterior ARC
(dmpARC), defined by expression of histamine 3 receptors
(Barrett et al. 2005). After switching to LD, VGF expression
in the dmpARC decreased rapidly, ahead of body weight
changes (Barrett et al. 2005). We have previously shown
that intracerebroventricular administration of the VGF-
derived peptide, TLQP-21, decreased appetite and body
weight in Siberian hamsters in LD (Jethwa et al. 2007),
supporting the view that the products of this gene might
impact upon seasonal behavior and physiology. In silico
analysis of the mouse VGF promoter sequence revealed a
potential thyroid response element (TRE), as well as a
vitamin D response element (VDRE). We previously
demonstrated that thyroid hormone (T3) availability in
the hypothalamus was likely to be reduced in hamstershttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
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Printed in Great BritainPY ONLYin SD, due to increase in DIO3 expression (Barrett et al.2007, Murphy et al. 2012), while changes in vitamin D
production have also previously been associated with
photoperiod, particularly in the human kidney and skin
(Webb et al. 1988, Holick 1995). Understanding the
interactions of these regulatory factors is necessary to
establish the mechanisms which promote the catabolic
state observed in Siberian hamsters in SD. Thus, we
investigated the effects of thyroid hormone (T3), RA and
vitamin D (1,25-dihydroxyvitamin D3 [1,25D3]) on VGF
mRNA expression and promoter activity in vitro. The
experimental approach was to use the SH-SY5Y neuro-
blastoma cell line, a common neuronal cell model due to
its ability to differentiate into a more mature neuron-like
phenotype and to be propagated unlike primary mamma-
lian neurons (Dwane et al. 2013, Kovalevich & Langford
2013). These in vitro studies were complemented by an
investigation of the effects of intra-hypothalamic implan-
tation of T3 on the expression of VGF in the hypothalamus
of Siberian hamsters, a procedure previously demonstrated
to maintain an anabolic phenotype characteristic of LD
exposure (Barrett et al. 2007, Murphy et al. 2012).Methods
Materials
Unless stated otherwise, all chemicals for cell culture were
purchased from Sigma–Aldrich, while those for RNA
extraction, complimentary DNA (cDNA) synthesis and
quantitative PCR (QPCR) were purchased from Roche
Life Science. RA, T3, and 1,25D3 were obtained from
Sigma–Aldrich and NGF was supplied by Millipore
(Telecula, CA, USA) and was diluted as per manufacturer’s
instructions. RA was reconstituted in 95% ethanol at
2.7 mg/ml; subsequent dilutions were made in DMEM
with a final ethanol concentration of 0.1% (v/v). NGF
(10 mg/ml) was reconstituted in sterile DMEM; subsequent
dilutions were made in sterile DMEM. T3 was reconstituted
in 1.0 ml 1.0 M NaOH (20 mg/ml) and 49 ml sterile DMEM;
subsequent dilutions were made in DMEM. 1,25D3 was
reconstituted in 95% ethanol (10 mM); subsequent
dilutions were made in sterile DMEM.Cell culture
The human neuroblastoma SH-SY5Y cells (a kind gift
from Dr Perry Barrett, but originally from European
Collection of Cell Cultures (ECACC) Centre for Applied
Microbiology and Research (CAMR), Porton Down Salisbury,Published by Bioscientifica Ltd.
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bovine serum (FBS), 100 units/l penicillin and 100 mg/l
streptomycin (DMEM/F12 complete) maintained at 37 8C
in a 95% humidified incubator with 5% CO2 (Lewis et al.
2015a). Although SH-SY5Y cells tend not to adhere very
well to uncoated plastic, they were routinely split 1:3 with
0.05% trypsin every 48 h.RNA extraction and cDNA synthesis
Prior to harvesting the cells, the DMEM/F12 complete
media was removed and cells were harvested in 200 ml of
RNase-free PBS. Total RNA was extracted from the cells
using the High Pure Isolation Kit (Roche) as described
previously (Brown et al. 2012). First-strand cDNA was
synthesized using the Transcriptor First Strand cDNA
Synthesis Kit (Roche), according to the manufacturer’s
protocol. The cDNA was stored at –20 8C.Quantitative RT-PCR
The PCR was performed with SYBR green optimized for the
LightCycler 480 (Roche Life Science). All reactions were
performed in triplicate on 384 well plates as described
previously (Brown et al. 2012). Transcript abundance was
determined from a standard curve produced using a serial
dilution of pooled cDNA made from all samples to check
linearity and efficiency of the PCR and the values
normalized to cyclophilin A, the most stable reference
gene under the experimental conditions. The respective
primer sets can be seen in Table 1.Synthesis of the VGF promoter and other constructs
First, the ZsGreen gene present in the promoter-
less pZsGreen1-1 vector (Clontech Laboratory) was
replaced with CBG992AmRFP from pCR2CBG992AmRFP
(pRFP, Stritzker et al. 2014). The subcloning strategy
utilized BamHI and NotI; then both fragments were
purified using the QIAquick gel extraction kit (QIAGEN),Table 1 The PCR primers used for QPCR analysis of gene expressio
Gene Forward primer (5 0–3 0)
Cyclophilin A TCCTGCTTTCAAGAATTATTCC
Map2 CATGGGTCACAGGGCACCTATT
Tau GCGGCAGTGTGCATATAGTCTA
Gap43 AGTGAGCAGCGAGCAGAA
VGF GACCCTCCTCTCCACCTCTC
VGF promoter AAGGGTGTGGGAGAGTTGG
http://jme.endocrinology-journals.org
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Printed in Great BritainPY ONLYas per manufacturer’s instructions. The pZsGreen1-1backbone was treated with calf intestinal alkaline phos-
phatase (Promega) to prevent re-ligation of the plasmid
without insert. This new reporter construct was designated
pRFP-basic and was transformed into JM109 cells (Promega).
Cultures were grown overnight, before plating and colony
selection. All purified plasmids were subjected to restriction
enzyme digestion and sequencing (performed by Source
BioScience, Nottingham, UK) to confirm identity. Subsequ-
ently a cytomegalovirus (CMV) promoter, from pLenti6.
4-CMV-C/EBPPA (a kind gift from Prof Michael Lomax,
University of Nottingham, UK), was cloned into the pRFP-
basic vector. Using a similar strategy, pRFP-basic was
digested with XhoI and SpeI, whilst pLenti6.4-CMV-C/
EBPPA was digested with SalI (which produces identical
overhangs toXhoI) and SpeI (NEB, Hitchin, Hertfordshire, UK)
to obtain the CMV promoter, which was subsequently
ligated into the pRFP construct. This new construct was
designated pCMV-RFP.
Approximately 1.1 kb of the mouse VGF promoter
(K1151 bp toC51 bp, relative to the transcriptional start
site; accession number: NM_001039385.1) was generated
by PCR (see Table 1 for primers). The resultant amplicon
was purified using the QIAquick gel extraction kit
(QIAGEN), as per manufacturer’s instructions, and inserted
into the pGEM-T-Easy vector for subsequent subcloning
into pRFP-basic using SpeI and SacI. Alternatively,MboI and
BglII were used to create the truncated 0.5 kb promoter
construct lacking the potential TRE and VDRE. The
orientation and authenticity of these constructs, desig-
nated pVGF1.1 and pVGF0.5, were verified by sequencing
(performed by Source BioScience, UK).Study 1: the long-term maintenance of differentiation
of SH-SY5Y cells
The SH-SY5Y cells demonstrate reduced neurite length,
a marker of differentiation, when cultured on uncoated
surfaces (Dwane et al. 2013). Therefore to establish culture
conditions for the long-term maintenance of differen-
tiated neuronal cells, SH-SY5Y cells were plated inn or to amplify 1.1 kb of the VGF promoter.
Reverse primer (5 0–3 0)
ATTCGAGTTGTCACAGTCAGC
C GGTGGAGAAGGAGGCAGATTAGCTG
CA GGAAGGTCAGCTTGTGGGTTTCAA
GTTGCGGCCTATGAGCTT
ACCGGCTCTTTATGCTCAGA
GAGGGATGGACAGCGGAG
Published by Bioscientifica Ltd.
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5!104 cells/cm2 in DMEM/F12 complete, and 24 h later
treated with 10 mM RA in DMEM/F12 complete for 120 h.
Differentiation was subsequently maintained by treating
the cells with 50 ng/ml NGF (Promega) in DMEM/F12
complete every 48 h. Images were captured 24, 48, 72, 96
and 120 h post-differentiation and neurite length
determined using ImagePro Software (version 4.0; Image
Pro, Rockville, MD, USA). A differentiated cell was defined
as a cell with a neurite length greater than the length of
the cell body. At the end of the study, cells were harvested
for RNA and subsequent QPCR to determine the
expression of the known markers of neurite differen-
tiation, microtubule-associated protein 2 (Map2), Tau and
growth-associated protein 43 (GAP43) (Table 1).Study 2: regulation of endogenous expression of
VGF mRNA in vitro
To investigate the regulation of endogenous VGF gene
expression, undifferentiated SH-SY5Y cells were plated
onto uncoated six-well plates for 24 h. Subsequently,
DMEM/F12 complete was removed and the cells treated
with DMEM/F12 complete containing 50 ng/ml NGF,
10 mM RA, 10 nM T3 or 10 nM 1,25D3 for 24 h. For studies
in differentiated SH-SY5Y cells, plates were coated with
10 mg/ml collagen type IV and differentiated as per study 1.
The adherent, differentiated cells were then treated with
DMEM/F12 complete containing 50 ng/ml NGF, 10 mM
RA, 10 nM T3 or 10 nM 1,25D3 for 24 h. Cells were
harvested for RNA extraction and QPCR to determine
endogenous expression of VGF.Study 3: regulation of VGF promoter activity in vitro
To investigate the regulation of the VGF promoter in
undifferentiated cells, SH-SY5Y cells were plated onto
uncoated six-well plates and grown to 70% confluence,
prior to transfection in DMEM/F12 basic medium
(DMEM/F12 containing 2.5% FBS, without antibiotics).
The undifferentiated cells were transfected with the
various plasmids using the FuGENE HD (reagent: DNA
ratio of 3:1) as per manufacturer’s instructions. Briefly,
undifferentiated cells were co-transfected with the VGF
promoter construct (pVGF1.1 or pVGF0.5) and tenfold
less pZsGreen1-N1 (Clontech Laboratories), a plasmid
containing a variant of green fluorescent protein (GFP)
under the control of a CMV promoter, with the latter
used to correct for differences in transfection efficiency.http://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great BritainPY ONLYpCMV-RFP (i.e. a strong promoter) was used as a positivecontrol, while pRFP-basic (a promoterless plasmid) was
used as a negative control, with both again being
co-transfected with pZsGreen1-N1 to normalize for varia-
bility in transfection efficiencies. Seventy-two hours post-
transfection, undifferentiated cells were switched back to
DMEM/F12 complete (with antibiotics) containing
50 ng/ml NGF, 10 mM RA, 10 nM T3, or 10 nM 1,25D3 for
48 h. Promoter activities (fluorescence) were quantified
at different time points using the Typhoon TrioC
(GE Healthcare, Little Chalfont, Buckinghamshire, UK).
In the experiments using differentiated cells, SH-SY5Y
cells were grown to 70% confluence on uncoated six-well
plates and transfected as before. The cells were then
harvested using 0.05% trypsin, plated onto six-well plates
coated with 10 mg/ml type IV collagen for 24 h, before
differentiation was induced with 10 mM RA for 120 h
(as before). Transfecting cells prior to differentiation have
been shown to result in higher transfection efficiencies
without altering the course of transgene expression
(Lahousse et al. 2006, Chu et al. 2009). Transfected,
differentiated cells were then treated with 50 ng/ml NGF,
10 mM RA, 10 nM T3, or 10 nM 1,25D3 for 48 h to
investigate effects on the VGF promoter activities (up to
120 h post-transfection). Promoter activities (fluor-
escence) were quantified at different time points using
the Typhoon TrioC (GE Healthcare).Study 4: the effects of intra-hypothalamic
T3 administration on VGF mRNA expression in
Siberian hamsters exposed to LD or SD
Hypothalamic expression of VGF was studied in tissues
collected in a study previously described by Barrett et al.
(2007). The study was carried out in age-matched adult
male Siberian hamsters obtained from a colony bred in
house (Ebling 1994), individually housed at constant
temperature (21G1 oC) and 40–50% humidity. Animals
had access ad libitum to food (Teklad 2019, Harland, UK)
and water throughout the studies. All animal procedures
were approved by the University of Nottingham Local
Ethical Review Committee and were carried out in
accordance with the UK Animals (Scientific Procedures)
Act of 1986 (Project License PPL 40/2372).
Anesthetized Siberian hamsters (aged 3–4 months)
maintained in LD had either T3 (mixture of crystalline T3
and medical grade silicone/Silastic-brand adhesive) or
sham (medical grade silicone/Silastic-brand adhesive
alone) microimplants placed bilaterally into the hypo-
thalamus (6.5 mm below the surface of the dura at 0.5 mmPublished by Bioscientifica Ltd.
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et al. 2007). At 12–16 days post-surgery, the Siberian
hamsters were subdivided according to bodyweight to be
either maintained in LD (nZ6/group) or transferred into
SD (nZ7–8/group). Animals were euthanized with sodium
pentobarbital (Euthatal: Rhone Merieux, Harlow) at 8
weeks post-surgery, and in situ hybridization studies for
VGF were carried out as previously described in Barrett
et al. (2005).
To determine expression slides were scored for the
density of silver grains over individual cells in the dmpARC
reflecting hybridization of the VGF probe by an observer
who was blind to the treatment: 0Zno hybridization, 1Za
few cells expressing VGF mRNA, 2Zmoderate VGF mRNA
expression cells, 3Zabundant VGF mRNA. Scores were not
possible for three animals as sections containing the
dmpARC region were not available.Statistical analysis
Data represent the meansGS.E.M. of six technical replicates
(i.e. wells). Significant differences between groups for
dependent variables were tested using either an unpaired,A Day 0
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Figure 1
Treatment of the SH-SY5Y cell line with 10 mM RA reduces cell proliferation
and increases differentiation. (A) Images of SH-SY5Y cells at days 0 and 5 of
differentiation in the absence or presence of 10 mM RA, showing differences
in cell numbers and morphology (neurite lengths). (B) Treatment of the
SH-SY5Y cell line with 10 mM RA significantly decreased cell number
(P!0.0001) and (C) significantly increased neurite length (a marker of
differentiation) (P!0.0001). (D) Neurite length was significantly greater
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Printed in Great BritainPY ONLYtwo-tailed Student’s t-test, one-way ANOVA in studies1 and 2 or a two-way ANOVA (treatmentxtime) in study 3.
In study 4, scores were analyzed by a Kruskal–Wallis test
with post hoc Dunn’s tests for multiple comparisons.
Changes in body weight (data represent the meansG
S.E.M.) and in paired testis weights over the course of the
T3 treatment were compared using one-way ANOVA with
post hoc Dunnett’s tests for multiple comparisons. Statisti-
cal analyses were conducted using GraphPad PRISM
(version 6.0, San Diego, CA, USA). Significance was
accepted at P!0.05.Results
Study 1: the long-term maintenance of differentiation
of SH-SY5Y cells
Treatment of the SH-SY5Y cells with 10 mM RA for 5 days
significantly reduced proliferation (Fig. 1A and B,
P!0.01). The cells underwent a significant change in
morphology, with the length of neurites significantly
increasing in response to 10 mM RA (Fig. 1A and C,
P!0.0001). By coating the cell culture wells with an
extracellular matrix protein such as poly-L-lysine or50 μm 20 μm
ys
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+5 days DMEM/F12-
complete + 10 μM RA
E
m
R
N
A 
fo
ld
 in
du
ct
io
n
(no
rm
ali
se
d t
o c
yc
lop
hil
in 
A)
Plastic Poly-L-lysine Collagen Map2
0
2
4
6
8
*
**
****
***
***
*
Tau Gap43
5 days post-treatment with differentiation media in wells coated with poly-
L-lysine or type IV collagen (P!0.0001) than plastic. (E) Treatment of the
SH-SY5Y cell line with differentiation media significantly increased Map2,
Tau and Gap43 (neuronal markers of differentiation). Gene expression was
quantified by QPCR, normalized to cyclophilin A mRNA, and then compared
to the normalized expression in undifferentiated cells. All values are meansG
S.E.M. (nZ6, *P!0.05, **P!0.01, ***P!0.001, and **** P!0.0001).
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and Gap43 mRNA were all significantly increased in
comparison to undifferentiated controls (Fig. 1E, P!0.05).
To ensure a homogenous population of differentiated
SH-SY5Y cells, differentiated cells were then treated with
50 ng/ml NGF every 48 h. Under these conditions, cultures
of differentiated cells could be maintained for up to 20 days
without reversion or cell death.Study 2: regulation of endogenous expression of
VGF mRNA in vitro
Treatment of undifferentiated SH-SY5Y cells with
50 ng/ml NGF for 24 and 48 h significantly increased
VGF mRNA five- and threefold (Fig. 2A, P!0.01 and
P!0.05 vs vehicle treated controls), while treatment with
10 mM RA significantly increased VGF mRNA two- and
fourfold at 24 and 48 h, respectively (Fig. 2A, P!0.05 vs
vehicle treated controls). Similar effects of NGF and
RA were observed in differentiated SH-SY5Y cells, but
the magnitude of the responses to NGF were bigger
(Fig. 2B). Further studies showed that treatment of
undifferentiated SH-SY5Y cells with 10 nM 1,25D3 for
24 h resulted in a threefold increase in VGF mRNA
(P!0.05), whereas treatment with 10 nM T3 resulted in a
fourfold decrease (P!0.01) in VGF mRNA (Fig. 2C), with
similar effects again observed in differentiated SH-SY5Y
cells, although the inhibitory effect of T3 tended to be
greater (Fig. 2D).Study 3: regulation of VGF promoter activity in vitro
Transfection of undifferentiated SH-SY5Y cells with
pVGF0.5 or pVGF1.1 (containing 0.5 and 1.1 kb of the
5 0 flanking region of the VGF promoter respectively15
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Figure 2
Treatment of undifferentiated or differentiated SH-SY5Y cells with NGF,
RA or 1,25D3 increases endogenous VGF mRNA expression, whereas T3
decreases endogenous VGF mRNA. VGF mRNA was significantly increased
by treatment with 50 ng/ml NGF or 10 mM RA for 24 and 48 h in both (A)
undifferentiated SH-SY5Y cells and (B) differentiated SH-SY5Y cells.
http://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great BritainPY ONLY(Fig. 3A)) resulted in significant increases in fluorescence,indicating promoter activity, but there was no difference
between them (PO0.05, Fig. 3B). Treatment of transfected
undifferentiated SH-SY5Y cells with either 10 mM RA or
50 ng/ml NGF resulted in significant increases in VGF
promoter activities, with NGF inducing a much faster
response than RA (time vs treatment interaction:
FZ27.94, P!0.0001, Fig. 3C). Similar time-dependent
effects of both NGF and RA were observed in differentiated
SH-SY5Y cells (time vs treatment interaction: FZ30.91,
P!0.0001, Fig. 3D). In both undifferentiated and differ-
entiated SH-SY5Y cells, treatment with NGF resulted in a
rapid induction of VGF promoter activity, whereas RA
showed a much slower response with a delayed onset. Given
the effect of T3 on endogenous VGF mRNA, transfected cells
for promoter studies were pre-treated with 50 ng/ml NGF for
1 h (to briefly induce promoter activity), before removal and
treatment with 10 nM T3. Treatment of undifferentiated or
differentiated SH-SY5Y cells with 10 nM T3 significantly
decreased promoter activity for the pVGF1.1 construct
(time vs treatment interaction: FZ86.13, P!0.0001,
Fig. 3E and F), while treatment with 10 nM 1,25D3 resulted
in a significant increase in pVGF1.1 promoter activity (time
vs treatment interaction: FZ14.58, P!0.0001, Fig. 3G and
H). There were no effects (PO0.05) of either 10 nM T3 or
10 nM 1,25D3 on activity of the truncated plasmid
(pVGF0.5), confirming that the response elements for the
two nuclear receptors were only present in the longer
promoter construct.Study 4: the effects of intra-hypothalamic
T3 administration on VGF mRNA expression in
Siberian hamsters exposed to LD or SD
As previously reported (Barrett et al. 2007) exposure to SD
for 8 weeks induced significant body weight loss (P!0.01,DUndifferentiated Differentiated
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meansGS.E.M. (nZ6, *P!0.05, **P!0.01 for comparisons between control
and treatment).
Published by Bioscientifica Ltd.
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Figure 3
Treatment of undifferentiated or differentiated SH-SY5Y cells with NGF,
RA or 1,25D3 increases VGF promoter activity, whereas T3 reduces VGF
promoter activity. (A) The VGF promoter (1.1 kb) was cloned into a
mammalian expression vector, based on the backbone of pZsGreen1-1
(Clontech), in which the GFP reporter gene was substituted for an mRFP.
A subsequent truncated promoter construct (0.5 kb), which lacked the
potential TRE and VDRE (indicated as *), was generated via 5 0 deletion.
(B) Promoter activities (fluorescence) were similar in cells transfected with
either the 1.1 or 0.5 kb VGF promoter constructs. Promoter activities are
shown relative to the positive control (pZsGreen1-N1, fluorescence set at
100%). VGF promoter activity (pVGF1.1 construct only) was increased by
50 ng/ml NGF and 10 mM RA in both (C) undifferentiated and (D)
differentiated SH-SY5Y cells. (C) SH-SY5Y cells were transfected with
pVGF1.1 and treated with NGF or RA 72 h post-transfection. 50 ng/ml
NGF rapidly induced pVGF1.1 promoter activity within 1 h (P!0.0001).
Ten micromolar RA resulted in a slower, yet significant, increase in
pVGF1.1 promoter activity, starting 6 h post-treatment (P!0.001).
(D) Undifferentiated cells were transfected as described in (B), but 72 h
post-transfection, cells were differentiated with 10 mM RA for 5 days.
Differentiated transfected cells were then treated with 50 ng/ml NGF or
10 mM RA for 48 h. Treatment of differentiated SH-SY5Y cells with NGF
(P!0.0001) and RA (P! 0.0001) had a similar effect to that observed in
transfected undifferentiated cells. VGF promoter activity (pVGF1.1
construct only) was decreased by 10 nM T3 in both (E) undifferentiated and
(F) differentiated SH-SY5Y cells, but there were no effects on the pVGF0.5
promoter construct (which lacked the potential TRE). Cells were
transfected and differentiated as described for (B) and (D) respectively, but
cells were pre-treated with DMEM/F12 complete containing 50 ng/ml NGF
for 1 h (to induce promoter activity) prior to addition of 10 nM T3, which
significantly reduced pVGF1.1 promoter activity (P!0.001) in both (E)
undifferentiated and (F) differentiated cells. Similarly, treatment with
10 nM 1,25D3 significantly increased pVGF1.1 promoter activities
(P!0.0001) in both (G) undifferentiated and (H) differentiated cells, but
there were no effects on the pVGF0.5 promoter construct (which lacked the
potential VDRE). pRFP-basic was included as a negative control in all
experiments to indicate background fluorescence, as this construct lacks a
functional promoter. All values are meansGS.E.M. (nZ6).J
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56 :2 129Fig. 4C) and testicular regression (P!0.001, Fig. 4D), and
both these physiological responses to SD were completely
blocked by intra-hypothalamic T3 implants (Fig. 4C and D).
As expected, a very low level of VGF expression was
observed in the dmpARC in hamsters which were
maintained in LD and received either intrahypothalamic
sham or T3 implants, that is a very small number of cells
in this region expressed VGF mRNA (Fig. 4A and B).
In contrast, VGF mRNA expression was abundant in the
dmpARC of sham-implanted hamsters exposed to SD for
8 weeks (P!0.001, Fig. 4A and B). Intra-hypothalamic
implantation of T3 significantly blocked this SD-induced
increase in VGF mRNA abundance (P!0.05, Fig. 4A and B).
Intrahypothalamic implantation of T3 had no effect on
VGF mRNA abundance or on any physiological para-
meters in hamsters that were maintained in LD (Fig. 4A, B,
C, and D). In the one hamster where the SD-inducedhttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great Britainincrease in VGF abundance was not prevented by the
T3 treatment, the SD-induced involution of the testes
was not blocked (Fig. 4D), and the hamster lost 3.3 g of
body weight thus the SD-induced catabolic response was
not prevented.Discussion
Tissue-specific expression of the VGF gene has been
previously described (Canu et al. 1997), but what other
regulatory elements are present within the promoter
remain to be established (Levi et al. 2004). Using the
human neuroblastoma SH-SY5Y cell line, we have demon-
strated that RA and NGF increase both endogenous VGF
mRNA expression and VGF promoter activity. The
increase confirms the rise in VGF mRNA demonstrated
in response to treatment with NGF in PC12 cells and toPublished by Bioscientifica Ltd.
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Figure 4
Intra-hypothalamic T3 administration reduces VGF mRNA expression in the
SD Siberian hamster. (A) representative photomicrographs of coronal
sections through the dmpARC counterstained with cresyl violet, VGF
hybridization is revealed by dark silver grains in the overlying emulsion in
Siberian hamsters exposed to LD or SD receiving intra-hypothalamic sham
or T3 implants for 8 weeks. Dotted line indicates approximate boundaries
of the dmpARC, arrow indicates induces expression in a SD sham hamster,
scale barZ100 mm. (B) analysis ofVGFmRNA abundance, scores for individual
animals are depicted; aP!0.001 vs LD sham group, bP!0.05 vs SD sham
group. (C) overall change in body weight, values are meanGS.E.M., **P!0.01
vs LD-sham group. (D) individual paired testis weights at the end of the study,
***P!0.001 vs LD-sham group. Weekly mean body weight data and group
mean testis weight data have been published previously (Barrett et al. 2007).
Circled values (panels (B) and (D)) are data from the same individual.
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56 :2 130RA in SK-N-BE cells (Levi et al. 1985, Cerchia et al.
2006). Whilst the increase in VGF mRNA and promoter
activity in response to treatment with NGF was rapid, it
was rather transient, decreasing after 24 h. In contrast,
treatment with RA resulted in a much slower-, longer-term
induction of VGF promoter activity, which continued to
increase through to 48 h.
In silico studies identified possible TRE and VDRE
sequences in the VGF promoter, and our studies have
shown that both endogenous VGF mRNA expression and
VGF promoter activity are suppressed by T3 treatment, but
increased with 1,25D3. Correspondingly, an in vivo
study revealed that intra-hypothalamic T3 administration
via slow-release microimplants reduced VGF mRNA
expression in the dmpARC of SD-exposed Siberian
hamsters. This suggests that VGF expression in vivo may
be regulated by availability of these hormones/ligands,
which in turn are determined by the transport of their
precursors and the enzymes responsible for synthesizing
or degrading their active forms. Substantial evidence
indicates that the generation of thyroid hormone and
RA signals in the mediobasal hypothalamus is regulated by
season and photoperiod (discussed by Ebling (2014,
2015)). For example, expression of the genes encoding
many of the components of the RA-signaling pathway
(cellular retinol-binding protein-1 (CRBP-1), cellularhttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great BritainRA-binding protein-2 (CRABP-2) and the nuclear
receptors, RAR and RXR) is reduced in response to SD in
the Siberian hamster (Ross et al. 2005, Barrett et al. 2006),
so this may explain why VGF mRNA expression is reduced
in the hypothalamus of Siberian hamsters exposed to SD
(Barrett et al. 2005). Furthermore, in a photoperiod-
responsive strain of rat, expression of RALDH-1, which
converts retinol to RA, is also reduced in the hypo-
thalamus in SD (Shearer et al. 2010). Transthyretin (TTR)
is a transporter for vitamin A and its metabolite RA as
well as T4. TTR binds T4 to establish a pool of T4 in the
plasma and cerebral spinal fluid (Prendergast et al. 2002)
as well as transporting retinol by binding to the RBP
(Hyung et al. 2010). However, studies utilizing TTR null
mice have shown that while there are reductions in retinol
and RBP in these mice, they display no symptoms of
vitamin A deficiency, suggesting that TTR is not crucial for
retinol delivery (Episkopou et al. 1993, van Bennekum
et al. 2001). Thus, local availability of RA is determined
by RALDH-1 and components of its signalling pathways
(CRBP-1, CRABP-2 and RAR and RXR). All of which, as
explained above, are reduced in response to SD in the
Siberian hamster (Ross et al. 2005, Barrett et al. 2006,
Shearer et al. 2010). Indeed, TTR expression in the
hypothalamus of Siberian hamsters has been reported
and the responsiveness of the gene was limited to thePublished by Bioscientifica Ltd.
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56 :2 131AUTHOR COphotorefractory state (Prendergast et al. 2002). TTR mRNAis strongly expressed in the ependymal layer of the
third ventricle and is decreased in SD (relative to LD)
(Helfer et al. 2012), thus resulting in reductions in local
T4 availability. This in combination with the reduction in
mRNA expression of DIO2 and increased expression and
activity of DIO3 is observed in Siberian hamsters main-
tained in SD (Watanabe et al. 2004, Barrett et al. 2007,
Herwig et al. 2009), and this results in a decrease in T3.
However, in the absence of RA, we suggest VGF expression
would remain low in the hypothalamus of hamsters
maintained in SD; thus we propose reduced RA in the
hypothalamus of Siberian hamsters in response to SD
results in reduced VGF expression (as demonstrated by
Barrett et al. (2005)).
Previously, both vitamin A and RXR ligands have been
shown to influence appetite (Anzano et al. 1979, Ogilvie
et al. 2004). Therefore, the reduction in the availability
of RA and components of its signaling pathway in the
hypothalamus of Siberian hamsters in SD and subsequent
reduction in VGF expression in the hypothalamus is a
possible explanation for the effects on appetite. The
complexity of the hormonal regulation of VGF expression
that the current study has revealed may also explain why
in SD there is a local upregulation of VGF expression in the
dmpARC. In the hamster, this region has a much higher
level of expression of thyroid hormone receptor b1 than
the surrounding hypothalamus (Barrett et al. 2007), and
our current study demonstrates that VGF mRNA
expression in the dmpARC is specifically regulated by
thyroid hormone. Thus, the SD-induced increase in DIO3
expression in tanycytes would be expected to reduce local
T3 availability, resulting in a loss of repression of VGF gene
expression in the dmpARC. Previously we demonstrated
effects of increasing hypothalamic T3 availability on the
behavior and physiology of SD-exposed Siberian hamsters.
Intra-hypothalamic T3 implants placed in hamsters in SD
produced a rapid increase in body weight, a reflection of
increased food intake and a decrease in energy expendi-
ture (Murphy et al. 2012). Here, we demonstrate that
locally increasing hypothalamic T3 blocks the SD-induced
increase in VGF mRNA expression in Siberian hamsters.
This is associated with a blockade of the SD-induced
decrease in appetite and in weight loss, and also with the
SD-induced inactivation of the reproductive axis. The
correlation between VGF expression in the dmpARC and
the physiological responses to SD was particularly high-
lighted in one individual hamster where the intrahypo-
thalamic T3 implants were ineffective in preventing any
of the SD responses, probably because their placementhttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great BritainPY ONLYwas too rostral to influence hypothalamic function. Thequestion now arises as to the specific role of T3-regulated
VGF expression in driving these seasonal responses. The
function of the dmpARC itself is not clear; as one recent
study found that SD-induced weight loss could occur in
hamsters with lesions of this structure (Teubner et al.
2015). However, other lines of evidence suggest that
increased VGF expression in the dmpARC could contrib-
ute to the SD-catabolic state, for example, at least one of
the peptide products (TLQP-21) has been shown to reduce
appetite when infused centrally into the hamster (Jethwa
et al. 2007).
Repression of VGF promoter activity was nullified via
the removal of the potential TRE from the promoter
construct. TREs have previously been shown to be
responsible for the dose-dependent T3 repression of Mc4r
promoter activity (Decherf et al. 2010). Furthermore, TREs
have been shown to function in combination with
RAR/RXR (De Luca 1991). Heterodimerization of the TR
with RXR favors the dissociation of suppressors and the
recruitment of activators of transcription (Cheung et al.
2009). Therefore, we hypothesize that the inability of TR
to heterodimerize with RXR results in the repression of
VGF in the hypothalamus of SD Siberian hamsters.
Additionally, we demonstrate that 1,25D3, the active
metabolite of vitamin D, significantly increases VGF
endogenous mRNA expression and promoter activity in
both undifferentiated and differentiated SH-SY5Y cells.
However, further studies are required to determine the
effects of 1,25D3 in vivo. The seasonal regulation of the
harderian gland of Siberian hamsters has been shown to be
regulated by vitamin D (Perez-Delgado et al. 1993, Stumpf
et al. 1993), while we have shown that plasma vitamin D3
levels in adult hamsters are significantly higher in SD than
in LD (SI Anderson, M Smith & FJP Ebling, unpublished
observations). Interestingly, 1,25D3 has been shown to
have neuroprotective qualities in vitro (Brewer et al. 2001,
Oermann et al. 2004, Wang et al. 2004), while treatment of
the SH-SY5Y cell line with 1,25D3 inhibits proliferation
(Celli et al. 1999), similar to the effects of RA. However,
long-term incubation with 1,25D3 only resulted in a slight
trend towards differentiation (Celli et al. 1999). More
recently, Agholme et al. (2010) demonstrated that pre-
treatment with RA followed by extracellular matrix gel
adhesion, in combination with brain-derived neuro-
trophic factor (BDNF), neuregulin B1, NGF and 1,25D3,
resulted in differentiated SH-SY5Y cells with unambiguous
resemblance to adult neurons. The results presented here
support the idea of differentiation-induced expression
of the VGF gene and, therefore a possible role inPublished by Bioscientifica Ltd.
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Figure 5
Schematic summary of the proposed photoneuroendocrine control of VGF
expression. Thyroxine (T4) is taken up from the circulation into tanycytes via
MCT8 transporters, and in LD is converted by DIO2 to T3 (Ebling 2014).
Furthermore, in LD, components of the retinoic acid-signaling pathway –
CRBP-1, CRABP-2, RAR, and RXR – are all upregulated in the Siberian hamster
(Ross et al. 2005, Barrett et al. 2006), while RALDH-1 is increased in the
photoperiodic rat (Shearer et al. 2010). We demonstrate that VGF expression
and promoter activity in SH-SY5Y cells is increased in response to treatment
with RA and vitamin D and reduced in response to treatment with T3.
Furthermore, VGF mRNA expression is reduced in response to intra-
hypothalamic T3 administration in the SD-exposed Siberian hamster. In SD,
expression of DIO3 is upregulated, and thus, inactive metabolites of T4 such
as rT3 and T2 are produced alongside reductions in components of the
retinoic acid-signaling pathway, while vitamin D plasma levels are increased.
This may account for the increase in VGF expression in the dmpARC whilst
reducing VGF expression in the ARC. Adapted from Ebling (2014).
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56 :2 132neurogenesis. This agrees with previous studies from
Esposito et al. (2008), who suggests that receptor tyrosine
kinase (RET) activation is a critical step in differentiation.
Indeed, Korecka et al. (2013) have shown that RA induces
RET expression in SH-SY5Y cells, while Cerchia et al.
(2006) have suggested that inhibition of RET in SK-N-BE
cells increases VGF expression. Moreover, a recent study in
mice has demonstrated that the VGF-derived peptide,
TLQP-62, directly increased the generation of neural
progenitor cells in the hippocampus and potentiated
BDNF-TrkB signalling (Thakker-Varia et al. 2014), thushttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-15-0224
 2016 The authors
Printed in Great Britainthe concept that enhanced VGF expression promotes
neurogenesis and plasticity is rapidly gaining ground.
In conclusion, this study demonstrates that T3 and
1,25D3, as well as NGF and RA, regulate endogenous VGF
expression and promoter activity in vitro, while T3
regulates VGF mRNA expression in vivo, providing a
possible mechanism for the seasonal regulation of appetite
in the Siberian hamster (Fig. 5), as well as suggesting a
possible role for VGF in neurogenesis. Furthermore,
it substantiates the central role of T3 and 1,25D3 in
neuroendocrine and metabolic signaling.Published by Bioscientifica Ltd.
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